Treatment pathways of lung cancer patients in the Czech Republic: insights from administrative claims data.

ABSTRACT:

Introduction

A patient pathway is an evidence-based tool that details the phases of care with the aim of increasing the effectiveness and efficiency of patient care. We describe diagnostic and treatment pathways and related overall survival (OS) of non-small cell lung cancer patients.

Methods

This was a longitudinal, historical descriptive cohort study based on administrative claim data, spanning from 2017 to 2022. The index date was determined by the first bronchoscopy with lung biopsy (BX) followed by histopathological (HP) examination, alongside the presence of the International Classification of Diseases 10th revision diagnosis code C34. Incident patients aged ≥18 without prior malignancy. Pharmacotherapies (PHT), including chemotherapy (PHT_CT), precision therapy (PHT_I

SUBMITTER: Tichopad A 

PROVIDER: S-EPMC12853478 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature